An Observational Study to Learn More About the Safety of Rivaroxaban in Participants With Peripheral Arterial Disease Who Had Surgery to Improve Blood Flow to Their Legs
Clinical trial NCT07142655 · COMPLETED
Trial details
- NCT number
- NCT07142655
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2025-08-12
- Primary completion
- 2026-03-09
- Enrollment
- 1500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.